A new Report by Delvens, titled "Immunohistochemistry (IHC) Market” offers a comprehensive analysis of the industry, which comprises insights on the Global analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period to 2028.
Get Free Sample Report: https://www.delvens.com/get-free-sample/immunohistochemistry-market
A laboratory method that uses antibodies to check for certain antigens (markers) in a sample of tissue. The antibodies are usually linked to an enzyme or a fluorescent dye. IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs).
The rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests are some of the factors that have supported long-term expansion for Immunohistochemistry (IHC) Market.
Key Players of Immunohistochemistry (IHC) Market:
· F. Hoffman-La Roche AG
· Danaher Corporation
· Agilent Technologies, Inc.
· Merck KGaA
· Bio-Rad Laboratories, Inc.
· Bio-Techne Corporation
· Abcam plc
· Becton, Dickinson and Company
· PerkinElmer, Inc.
· Takara Bio, Inc.
· Thermo Fisher Scientific, Inc.
· PHC Holdings Corporation
· Cell Signaling Technology, Inc.
· Bio SB, Inc.
· Miltenyi Biotec
· CANDOR Bioscience GmbH
· Sakura Finetek Japan Co., Ltd. and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/immunohistochemistry-market
Recent Developments
In August 2021, Roche received FDA approval for VENTANA MMR RxDx companion diagnostic test based on immunohistochemistry for solid tumors that are deficient in the MMR pathway. The test identifies patients eligible for GSK’s anti-PD1 immunotherapy, JEMPERLI.
In August 2021, Agilent received a CE-IVD mark in Europe for its PD-L1 IHC 22C3 pharmDx assay for the identification of oesophageal cancer patients for treatment with KEYTRUDA.
Regional Analysis
North America was the largest regional market for immunohistochemistry market in 2020. APAC is expected to register the fastest growth rate during the forecast period owing to several factors, including increasing disposable income, rising healthcare spending, growing demand for quality medical care, and increasing investments by pharmaceutical and biopharmaceutical companies.
Reasons to Acquire:
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
· Gain authentic and granular data access for Immunohistochemistry (IHC) Market so as to understand the trends and the factors involved behind changing market situations
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Immunohistochemistry (IHC) Market is segmented into product, application, end user and region.
On the basis of Product
· Antibodies
· Reagents
· Equipment
· kits
On the basis of Application
· diagnostic applications
· research applications
· forensic applications
On the basis of End-User
· Hospitals & Diagnostic Laboratories
· Academic & research Institutes
· Other end users (CROs, pharma & biopharma companies, and forensic laboratories)
On the basis of Region
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
Access Full Report: https://www.delvens.com/report/immunohistochemistry-market
In addition to the market data for Immunohistochemistry (IHC) Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.
More Related Reports:
Automotive Diagnostic Scan Tools Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
